Related references
Note: Only part of the references are listed.ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications
Peter Valent
PATHOBIOLOGY (2019)
The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms
Manja Meggendorfer et al.
HAEMATOLOGICA (2018)
Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes
Eva J. Schaefer et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone
Mrinal M. Patnaik et al.
LEUKEMIA (2018)
The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms
Manja Meggendorfer et al.
HAEMATOLOGICA (2018)
Making Sense of Prognostic Models in Chronic Myelomonocytic Leukemia
Aziz Nazha et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2018)
What biologic factors predict for transformation to AML?
Rafael Bejar
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2018)
Cell-lineage level-targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes
Kazuaki Yokoyama et al.
BLOOD ADVANCES (2018)
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
Maximilian Stahl et al.
BLOOD ADVANCES (2018)
How we diagnose and treat systemic mastocytosis in adults
Robyn M. Scherber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies
Michael W. Drazer et al.
BLOOD ADVANCES (2018)
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima et al.
NATURE GENETICS (2017)
Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes
L. Guidugli et al.
LEUKEMIA (2017)
Practical considerations for diagnosis and management of patients and carriers
Charlotte M. Niemeyer et al.
SEMINARS IN HEMATOLOGY (2017)
Recognition of familial myeloid neoplasia in adults
Anna L. Brown et al.
SEMINARS IN HEMATOLOGY (2017)
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia
Elliot Stieglitz et al.
NATURE COMMUNICATIONS (2017)
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
Peter Valent et al.
ONCOTARGET (2017)
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling et al.
NATURE REVIEWS CANCER (2017)
Gene expression and risk of leukemic transformation in myelodysplasia
Yusuke Shiozawa et al.
BLOOD (2017)
Somatic HLA mutations expose the role of class I-mediated autoimmunity in aplastic anemia and its clonal complications
Daria V. Babushok et al.
BLOOD ADVANCES (2017)
Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML
Dorothee Selimoglu-Buet et al.
BLOOD (2017)
Clinical significance of somatic mutation in unexplained blood cytopenia
Luca Malcovati et al.
BLOOD (2017)
Recent advances in understanding clonal haematopoiesis in aplastic anaemia
Natasha Stanley et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
Theo de Witte et al.
BLOOD (2017)
Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis
Chetasi Talati et al.
BLOOD (2017)
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+advanced systemic mastocytosis
M. Jawhar et al.
LEUKEMIA (2016)
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
Courtney D. DiNardo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Hypomethylating Agents as Bridging Therapy before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myelomonocytic Leukemia?
Marie Robin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Time-dependent changes in mortality and transformation risk in MDS
Michael Pfeilstoecker et al.
BLOOD (2016)
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Vascular events and risk factors for thrombosis in refractory anemia with ring sideroblasts and thrombocytosis
M. M. Patnaik et al.
LEUKEMIA (2016)
A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia
Srinivas K. Tantravahi et al.
LEUKEMIA & LYMPHOMA (2016)
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Jason Gotlib et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Jane Merlevede et al.
NATURE COMMUNICATIONS (2016)
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
Jane E. Churpek et al.
BLOOD (2015)
Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression
Catherine A. Cargo et al.
BLOOD (2015)
MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
Brian Kwok et al.
BLOOD (2015)
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I. Mughal et al.
HAEMATOLOGICA (2015)
Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes
Aziz Nazha et al.
HAEMATOLOGICA (2015)
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia
Kristen Meldi et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
M. Jawhar et al.
LEUKEMIA (2015)
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network
Aurelie Caye et al.
NATURE GENETICS (2015)
The genomic landscape of juvenile myelomonocytic leukemia
Elliot Stieglitz et al.
NATURE GENETICS (2015)
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia
T. Yoshizato et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia
T. L. Lasho et al.
BLOOD CANCER JOURNAL (2015)
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies
E. Padron et al.
BLOOD CANCER JOURNAL (2015)
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I. Mughal et al.
HAEMATOLOGICA (2015)
Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes
Aziz Nazha et al.
HAEMATOLOGICA (2015)
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley et al.
BLOOD (2015)
Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations
Sabine Jeromin et al.
HAEMATOLOGICA (2015)
Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia
Nathalie Cervera et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study
Emnet A. Wassie et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang et al.
BLOOD (2014)
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome
Austin G. Kulasekararaj et al.
BLOOD (2014)
The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT
S. E. Langabeer et al.
BONE MARROW TRANSPLANTATION (2014)
The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells
Barbara Peter et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia
M. W. Drummond et al.
LEUKEMIA (2014)
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
M. M. Patnaik et al.
LEUKEMIA (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
M. Ryan Corces-Zimmerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment
Jason Gotlib et al.
BLOOD (2013)
Comprehensive mutational profiling in advanced systemic mastocytosis
Juliana Schwaab et al.
BLOOD (2013)
ANKRD26-related thrombocytopenia and myeloid malignancies
Patrizia Noris et al.
BLOOD (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
A. Pardanani et al.
LEUKEMIA (2013)
Somatic SETBP1 mutations in myeloid malignancies
Hideki Makishima et al.
NATURE GENETICS (2013)
Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia
Hirotoshi Sakaguchi et al.
NATURE GENETICS (2013)
Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML
Julia E. Maxson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Does a Diagnosis of Myelogenous Leukemia Require 20% Marrow Myeloblasts, and Does <5% MarrowMyeloblasts Represent a Remission? The History and Ambiguity of Arbitrary Diagnostic Boundaries in the Understanding of Myelodysplasia
Marshall A. Lichtman
ONCOLOGIST (2013)
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer et al.
BLOOD (2012)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis
Julien Broseus et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib
Karoline V. Gleixner et al.
BLOOD (2011)
Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia
Takamasa Katagiri et al.
BLOOD (2011)
SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes
Manuel G. Afable et al.
BLOOD (2011)
Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99
Jakob R. Passweg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis
Gerwin Huls et al.
BLOOD (2010)
RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
Clara Ricci et al.
CLINICAL CANCER RESEARCH (2010)
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
Ken-Hong Lim et al.
BLOOD (2009)
Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
Animesh Pardanani et al.
BLOOD (2009)
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
Hagop Kantarjian et al.
CANCER (2008)
Unique effects of KIT D816V in BaF3 cells: Induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens
Matthias Mayerhofer et al.
JOURNAL OF IMMUNOLOGY (2008)
HLA association is different in children and adults with severe acquired aplastic anemia
Monika Fuehrer et al.
PEDIATRIC BLOOD & CANCER (2007)
Prognostic factors and risk assessment in chronic myelomonocytic leukemia: Validation study of the M. D. Anderson prognostic scoring system
Miloslav Beran et al.
LEUKEMIA & LYMPHOMA (2007)
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome
JP Maciejewski et al.
BLOOD (2001)
Share Paper
